Cancer Exercise App
BehavioralUse of Cancer Exercise app to increase physical activity levels among cancer survivors.
NCT Number: NCT07535918
The Cancer Exercise app (CEA) is designed to promote physical activity among cancer survivors. The proposed randomized controlled clinical trial will investigate, in adults who have completed cancer treatment, the effects of a 12-week home-based exercise program, delivered using CEA, on physical activity levels. Participants will be randomized into one of two groups: (1) CEA or (2) Usual Care.
Trial opening soon.
Get NotifiedHealthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of Cancer Exercise app to increase physical activity levels among cancer survivors.
Time frame: Baseline and following the 12-week intervention
Moderate to vigorous physical activity will be assessed using the International Physical Activity Questionnaire, a well-validated and reproducible questionnaire for use among cancer survivors
Contact information is provided by the study sponsor or research team.
University of Florida
Other
Using e-Technologies to Maximize Physical Activity After Cancer Treatment: The eMPACT Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735442
Cancer, Neoplasms
Boston, Massachusetts, United States
View Trial DetailsNCT07731425
Cancer, Neoplasms
Boston, Massachusetts, United States
View Trial DetailsNCT07729696
Anxiety, Anxiety Disorders
Denpasar, Bali, Indonesia
View Trial DetailsNCT07727031
Cancer, Mouth Diseases
View Trial Details